Kyoto University Innovation Capital

Kolagen Pharma develops and sells pharmaceuticals, medical devices, and research reagents, and manufactures cosmetics, focusing on collagen-based biomaterials for regenerative medicine.

BiotechHealthtechLongevityMedical DevicesKyoto, JP

Hiroshi Nose(代表取締役 (Representative Director))

Junji Adachi(Founder)in

Co-investorsCelesta CapitalCelesta CapitalDBJ CapitalMCP Asset ManagementMIRAI SOUZOUShizuoka Capital+2 more

Co-investorsDBJ CapitalAbies Ventures

ACT Genomics is a cancer genomics company that provides genomic testing solutions to support personalized cancer care and precision medicine for patients and clinicians.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsUMC Capital

AlphaNavi Pharma is a pharmaceutical company developing new drugs (Nav channel inhibitors) for patients suffering from chronic pain and neurological disorders.

BiotechDigital HealthHealthtech京都市, JP

小山田義博Yoshihiro Oyamada(Representative Director)

Co-investorsShinsei Capital Partners

The Audio Metaverse creates a bridge between physical and virtual spaces through audio, allowing users to own audio spaces as unique digital assets with exclusive access features.

Creator Economy

BTB Therapeutics develops a non-opioid analgesic aimed at addressing the opioid crisis, along with a pipeline of RNA-modifying compounds for rare genetic diseases and to enhance cancer immunotherapy.

BiotechHealthtechMedical DevicesEscondido, US

Masatoshi Hagiwara(Chief Scientific Officer, Director of the Board (founder of BTB Therapeutics Co., Ltd.))Takashi Kiyoizumi(CEO, Director of the Board)Kenneth W. Locke(Chief Development Officer)

Cancer therapeutics development (RNA regulation abnormalities).

Co-investorsNippon Venture CapitalShinsei Capital PartnersSMBC Venture CapitalUTokyo Innovation Platform Co. Ltd.

Cleanhearing develops Sono, a patented technology aimed at treating tinnitus.

Digital HealthHardwareHealthtechMedical Devices

Gerald Neuwirth(Founder / Technical Lead)Lydia Mitchell(Head of Product & Operations)

BoardHidero Niioka

CONNEXX SYSTEMS is a Japanese startup developing energy-storage batteries and a networked storage system ("Power Net") that links distributed batteries and renewable sources like solar and wind into a unified energy network.

CleantechEnergyHardware

Co-investorsUniversal Materials Incubator

Development of novel gene-related therapies.

GraGreen develops improved crop varieties using genome editing and traditional breeding methods to reduce resource inputs and increase agricultural yields.

AgTechClimate TechNagoya, JP

Masaki Niwain

Co-investorsBeyond Next VenturesSeiho Investment WorksShizuoka CapitalTechstarsUTokyo Innovation Platform Co. Ltd.

Kanjin Therapeutics is a biotechnology startup developing treatments to restore kidney function and address chronic kidney diseases, using a strategy of targeting the liver.

BiotechDigital HealthHealthtechMedical Devices

Kyoto Fusioneering develops fusion energy technology and related engineering solutions to enable carbon-neutral power generation and advanced chemical processes such as hydrogen production and carbon capture.

Climate TechDeep TechEnergyKyoto, JP

Taka Nagao(Founder)inShutaro Takeda, Ph.D.(Founder)in

Co-investorsCoral CapitalDBJ CapitalGlobal BrainJIC Venture Growth InvestmentsSumitomo Mitsui Trust nvestment Co. Ltd.Techstars+2 more

Co-investorsKobe University Capital

Myoridge develops serum-free cell culture media and optimization services for cell cultivation and regenerative medicine applications.

BiotechHealthtechMedical DevicesJapan, JP

Co-investorsBeyond Next VenturesDiamond Edge Ventures

Perseus Proteomics (PPMX) is a Japanese biotech company that uses proprietary antibody technology to develop new antibody-based drugs.

BiotechDeep TechHealthtech

Co-investorsDBJ CapitalNewton BiocapitalNippon Venture CapitalSMBC Venture Capital

Platform for high-throughput material property simulation based on quantum mechanics.

Cambridge, US

Toru Shiozaki(Executive Officer, Director)

BoardGuanhua Chen(Director)Garnet Chan(Director)

Co-investorsAbies VenturesUTokyo Innovation Platform Co. Ltd.Embark Ventures

RadioNano Therapeutics is a drug discovery startup developing new radiation-based cancer therapies rooted in basic science.

BiotechHealthtechMedical Devices

Masatoshi Chiba(代表取締役社長 (President & CEO))

Co-investorsDBJ Capital

RegCell Biosciences is a biotechnology company developing regenerative cell therapies, leveraging expertise in cell and gene therapy, manufacturing, and immunology to advance therapeutic treatments.

BiotechDeep TechMedical Devices

Michael McCullar, PhD(Chief Executive Officer)James Ahlers(Chief Financial Officer)Marty Giedlin, PhD(Chief Technology Officer)Tony Hurley(Chief Technical Operations Officer)Steve Kanner, PhD(Chief Scientific Officer)

Co-investorsFast Track InitiativeGlobal BrainUTECMitsubishi UFJ Capital

Restore Vis is a life sciences company founded by a vitreoretinal surgeon and clinician scientist focused on addressing inflammation, aging, neurodegeneration and angiogenesis through translational research from drug discovery to clinical trials.

BiotechDigital HealthHealthtechMedical DevicesTokyo, JP

Dr. Rajendra S. Apte(Paul A. Cibis Distinguished Professor; Vice Chair of Innovation and Translation; Founder)

Co-investorsAstellas Venture Management LLCDBJ CapitalJIC Venture Growth InvestmentsNippon Venture CapitalOSAKA University Venture CapitalRemiges Ventures, Inc.+3 more

Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsAstellas Venture Management LLCF-Prime CapitalFast Track InitiativeJIC Venture Growth Investments

Koji Itoin

Co-investorsBeyond Next VenturesGlobal BrainEnergy & Environment Investment

U-MAP is a University of Nagoya spin-off developing new thermal-management materials to address heat problems in electronic devices such as smartphones, PCs, electric vehicles, data centers, and 5G equipment.

Deep TechHardwareNew MaterialsNagoya, JP

Co-investorsGlobal BrainUntroD Capital

Viage Therapeutics is a neuroscience drug developer working on novel oral neurotherapeutics that target the gut-brain axis, including its lead clinical candidate DGX-001 for cognitive impairment in conditions such as Alzheimer's and Parkinson's disease.

BiotechDeep TechHealthtechSan Francisco Bay Area, US

Titus Plattel(Leadership Team)inBrian Rogers(Leadership Team)inNeil Schwartz(Leadership Team)inSujata Sankar(Leadership Team)inSteven King(Leadership Team)in

Co-investorsMiyako CapitalRDiscoveryRemiges Ventures, Inc.

Advance Composite develops and manufactures advanced composite materials aimed at supporting industrial development while reducing environmental impact through energy and resource efficiency.

Advanced ManufacturingCleantechNew Materials

Junichi Hattori(代表取締役社長 (President & Representative Director))

Co-investorsEnergy & Environment Investment

eSep Inc. develops and provides nanoceramics membrane separation technology and related equipment and systems for chemical processes and energy applications.

Advanced ManufacturingCleantechNew MaterialsKyoto, JP

Kenichi SawamuraKen-ichi SAWAMURA(Founder)in

Co-investorsGlobal BrainHiroshima Venture Capital Co. Ltd.Kobe University Capital

EneCoat Technologies develops and manufactures perovskite solar cells (PSCs) and related materials.

CleantechEnergyNew MaterialsKyoto, JP

加藤尚哉 (Naoya Kato)(Representative Director / Executive Officer / CEO)堀内保 (Tamotsu Horiuchi)(Director / Executive Officer / CTO)

Co-investors15th RockGlobal BrainMIRAI SOUZOUMonozukuri VenturesNippon Venture Capital

Biotech

Co-investorsJDRF T1D Fund

Cuorips develops regenerative medicine products based on human iPS cell technology, including its heart muscle cell sheet "Heart®" (Rehart) for treating severe heart failure caused by ischemic cardiomyopathy, along with catheter-based therapies and compound drugs (YS series).

BiotechHealthtechMedical DevicesOsaka, JP

Takayuki Kusanagi(Representative Director, President & CEO)Tadayuki Tanimura(Director, Executive Vice President)Kazuyoshi Hirao(Director, Executive Vice President & Chief Business Officer)Yoshiki Sawa(Director, Chief Medical Science Officer)

Co-investorsNippon Venture Capital

Co-investorsNippon Venture Capital

Sunlit Seedlings Co., Ltd. describes its SDGs initiatives and its fraud-prevention policy for managing public research funds, stating it operates and manages competitive research funding in line with guidelines for the administration and auditing of public research expenses at research institutions.

AgTechCircular EconomyClimate TechDeep TechImpact & Social Good

tiem factory Inc. develops, manufactures, and sells functional materials, specifically an aerogel called SUFA (Super Functional Air), a porous material over 90% air engineered for high flexibility and elasticity in transparent plate form.

CleantechDeep TechNew MaterialsIbaraki, JP

橘弘一郎(代表取締役社長 (President & CEO))倉田真弥(取締役 / 代表取締役 (Director / Representative Director))

Board川瀬昇(取締役 (Director))

Co-investorsUniversal Materials Incubator

Tokiwa Bio develops the Stealth-type RNA vector (SRV™), a non-integrating gene delivery vector that can introduce multiple or large genes into cells at high efficiency for gene therapy.

BiotechDeep TechMedical Devices

Toregem Biopharma is a Kyoto University spin-off developing a tooth-regeneration drug based on a humanized anti-USAG-1 antibody that aims to regrow teeth with a single injection.

BiotechDeep TechHealthtechMedical Devices京都 (Kyoto), JP

喜早 ほのか (Honoka Kihayashi)(代表取締役社長 (Representative Director and President))髙橋 克 (Katsu Takahashi)(取締役CTO (Director and CTO))髙谷 宗男 (Muneo Takaya)(取締役CBO (Director and CBO))喜早 ほのか(Co-founder & CEO (代表取締役社長))髙橋 克(Co-founder & CTO)髙谷 宗男(Co-founder & CBO)

Co-investorsAstellas Venture Management LLC

FIMECS, Inc. is a Japanese drug discovery company researching and developing new pharmaceuticals based on targeted protein degradation mechanisms.

BiotechMedical DevicesFujisawa, JP

Kanae Kamo(代表取締役 CEO (Representative Director & CEO))

Co-investorsUTokyo Innovation Platform Co. Ltd.

Physiologas develops technology to innovate healthcare and improve patient and family wellbeing.

Digital HealthHealthtechMedical Devices

HoloBio is a Japanese molecular biology research company that studies the unique functions of region-specific plants, animals, and symbiotic microorganisms across Japan.

AgTechBiotechDeep TechFoodTechKyoto, JP

Masato Umeda(Representative Director & President (Founder))Toshihide Kobayashi(Director & Head of Research)Kinya Nakaoka(Director & Head of Corporate Planning)

Co-investorsGenesia Ventures

Co-investorsGlobal Brain

Melody International develops mobile fetal and maternal monitoring medical devices, including the "iCTG" cardiotocograph and the "Central i" central monitoring system for perinatal care.

Digital HealthFemTechHealthtechMedical DevicesTakamatsu, JP

Ichiro Matsubara(Representative Director / CEO)

Atsushi Alex Mazawa(Founder)in

Co-investorsBeyond Next VenturesGlobal Brain

Rege Nephro develops regenerative medicine therapies for kidney disease, focusing on nephron progenitor cell research and differentiation from iPS cells.

BiotechHealthtechMedical DevicesKyoto, JP

Co-investorsGlobal BrainNippon Venture Capital

aceRNA Technologies develops therapies based on RNA technology, focusing on the discovery of new functions of miRNA to contribute to regenerative medicine and the creation of new drugs for diseases that currently lack treatments.

BiotechDeep TechHealthtechMedical DevicesTokyo, JP

須川史啓(代表取締役 (Representative Director / CEO))

Sakanotochu sells produce grown with low-environmental-impact farming methods, sourcing from roughly 300 farms mainly in western Japan, about 80% of them new-entry farmers.

AgTechDirect to ConsumerE-commerceFoodTechKyoto, JP

小野 邦彦(代表者 (Representative))Kunihiko Ono(Founder)

AFI manufactures rapid microbial detection systems using flow cytometry and solid-phase cytometry technologies for quality control in pharmaceuticals, clinical diagnostics, cosmetics, food and beverage, and environmental testing.

HardwareHealthtechMedical DevicesTokyo, JP

Co-investorsOSAKA University Venture Capital

Arktus develops regenerative medicine using iPS cell-derived cartilage implants for knee cartilage repair, combining iPS cell research from Kyoto University with cell 3D-printing technology from Saga University.

BiotechLongevityMedical Devices

Tomohiro Oiwa(Representative Director (CEO))

BoardKoichi Nakayama(Outside Director / Professor, Saga University School of Medicine)Makoto Ikeya(Outside Director / Associate Professor, Kyoto University CiRA (iPS Cell Research Institute))

Co-investorsBeyond Next VenturesScrum Ventures

FLOSFIA develops power semiconductor devices based on corundum-structure gallium oxide (α-Ga₂O₃), a material originating from Kyoto University in Japan, using its proprietary water-based "MISTEPITAXY" mist deposition process to achieve lower loss than SiC at silicon-level cost.

CleantechDeep TechNew MaterialsSemiconductorsKyoto, JP

人羅俊実(創業者・取締役会長 (Founder & Chairman))四戸孝(代表取締役社長 (President & CEO))

Co-investorsMiyako CapitalUTECEnergy & Environment Investment

Co-investorsKeio Innovation InitiativeOSAKA University Venture Capital

KOALA Tech Inc. is a Kyushu University spinout commercializing organic semiconductor laser diode (OSLD) technology as laser light sources compatible with organic electronic device platforms, including OLED displays.

Deep TechHardwareSemiconductorsFukuoka, JP

安達千波矢(Founder (Kyushu University Professor))Chihaya Adachi(Co-founder (Kyushu University Professor))Fatima Bencheikh(Representative Director, CEO & CTO)in

Co-investorsSony Ventures Corporation

Lang-8 operates HiNative, a Q&A platform where users worldwide ask and answer questions about languages and cultures for mutual language learning.

ConsumerEdTechSocial

Co-investorsDG IncubationOpen Network LabZ Venture Capital